Merck (NYSE:MRK) reported positive Phase 3 results for tulisokibart, an anti-TL1A monoclonal antibody in moderate-to-severe ...
Once regarded as a disease affecting people over the age of 50, colorectal cancer is now rising at an alarming rate among ...
A quiet layer of biology is beginning to change how health is understood, and it sits on the surface of nearly every cell in ...
DRB1*01:03 allele was associated with severe outcomes across inflammatory bowel disease subtypes, including perianal complications, advanced therapy use and surgical interventions, according to study ...
The Rome V criteria for IBS identified a different group of patients, with lower sensitivity than either Rome III or IV ...
Tresca is a writer and speaker who covers digestive conditions, including IBD. She was diagnosed with ulcerative colitis at age 16. Suzanne Fisher, RD, is a registered dietitian and licensed ...
Brendan Camp, MD, FAAD, is a double board-certified dermatologist and assistant professor of dermatology at Weill Cornell Medical College. Five to 30 minutes of sun exposure on most days without ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results